Triple
T4210287
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Office of Rare Diseases Research |
E93883
|
entity |
| Predicate | supportsProgram |
P178
|
FINISHED |
| Object |
Rare Diseases Registry Program
The Rare Diseases Registry Program is an initiative that helps develop and maintain patient registries to advance research, understanding, and treatment of rare diseases.
|
E421898
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Rare Diseases Registry Program | Statement: [Office of Rare Diseases Research, supportsProgram, Rare Diseases Registry Program]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Rare Diseases Registry Program Context triple: [Office of Rare Diseases Research, supportsProgram, Rare Diseases Registry Program]
-
A.
Office of Rare Diseases Research
The Office of Rare Diseases Research is a U.S. government program that coordinates and supports research, information, and collaboration efforts focused on rare diseases.
-
B.
Therapeutics for Rare and Neglected Diseases program
The Therapeutics for Rare and Neglected Diseases program is a U.S. government initiative that accelerates the discovery and development of new treatments for rare and underserved diseases that lack adequate commercial investment.
-
C.
The Jackson Laboratory for Genomic Medicine
The Jackson Laboratory for Genomic Medicine is a biomedical research institute specializing in genomics and precision medicine, focusing on understanding the genetic basis of disease to advance diagnostics and therapies.
-
D.
National Center for Advancing Translational Sciences
The National Center for Advancing Translational Sciences is a U.S. biomedical research center focused on accelerating the development and delivery of new diagnostics, treatments, and cures by improving the translational science process.
-
E.
Cystic Fibrosis Research Center
The Cystic Fibrosis Research Center is a specialized research facility at the UNC School of Medicine focused on advancing understanding and treatment of cystic fibrosis through basic, translational, and clinical studies.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Rare Diseases Registry Program Triple: [Office of Rare Diseases Research, supportsProgram, Rare Diseases Registry Program]
Generated description
The Rare Diseases Registry Program is an initiative that helps develop and maintain patient registries to advance research, understanding, and treatment of rare diseases.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Rare Diseases Registry Program Target entity description: The Rare Diseases Registry Program is an initiative that helps develop and maintain patient registries to advance research, understanding, and treatment of rare diseases.
-
A.
Office of Rare Diseases Research
The Office of Rare Diseases Research is a U.S. government program that coordinates and supports research, information, and collaboration efforts focused on rare diseases.
-
B.
Therapeutics for Rare and Neglected Diseases program
The Therapeutics for Rare and Neglected Diseases program is a U.S. government initiative that accelerates the discovery and development of new treatments for rare and underserved diseases that lack adequate commercial investment.
-
C.
The Jackson Laboratory for Genomic Medicine
The Jackson Laboratory for Genomic Medicine is a biomedical research institute specializing in genomics and precision medicine, focusing on understanding the genetic basis of disease to advance diagnostics and therapies.
-
D.
National Center for Advancing Translational Sciences
The National Center for Advancing Translational Sciences is a U.S. biomedical research center focused on accelerating the development and delivery of new diagnostics, treatments, and cures by improving the translational science process.
-
E.
Cystic Fibrosis Research Center
The Cystic Fibrosis Research Center is a specialized research facility at the UNC School of Medicine focused on advancing understanding and treatment of cystic fibrosis through basic, translational, and clinical studies.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69b3451743608190808f41d17ccf2650 |
completed | March 12, 2026, 10:58 p.m. |
| NER | Named-entity recognition | batch_69b34810de648190b09c5e705cf0a74e |
completed | March 12, 2026, 11:11 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69b5962ec4f8819085bef81ce71aa132 |
completed | March 14, 2026, 5:09 p.m. |
| NEDg | Description generation | batch_69b596eb6c288190a63c61d5e71c609b |
completed | March 14, 2026, 5:12 p.m. |
| NED2 | Entity disambiguation (via description) | batch_69b59788ef308190a34c2f23f22a7e4d |
completed | March 14, 2026, 5:14 p.m. |
Created at: March 12, 2026, 11:03 p.m.